Evotec Evotec, Takeda Pharmaceuticals Partner on RNA-Targeting Drug Development The companies will work together to identify and develop small molecule drugs against RNA targets that fit within Takeda's disease areas of focus. Evotec, Indivumed to Collaborate on Non-Small Cell Lung Cancer Drug Discovery The deal comes on the heels of a colorectal cancer-focused drug-discovery alliance that the German companies formed in early 2019. Evotec, Celmatix Partner on Women's Reproductive Health Drug Discovery About a year ago, New York City-based Celmatix launched a division to discover therapeutics for women's health indications including reproductive disorders. Evotec Acquires iPSC Drug-Discovery Assets From Ncardia The assets include intellectual property relevant to iPSC-based phenotypic drug discovery and an existing product business around iPSC-derived cells. Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery Evotec will access Indivumed's IndivuType multi-omics cancer database to discover and develop new precision therapeutics for colorectal cancer. Sep 6, 2018 Evotec, Celgene Partner on Targeted Protein Degradation for Drug Discovery Aug 27, 2018 Centogene, Evotec Forge Drug-Discovery Alliance May 2, 2018 Evotec Licenses CRISPR-Cas9 Technology From ERS Dec 4, 2017 Ncardia, Evotec Sign Licencing Agreement for iPS Cell Disease Modeling Aug 4, 2017 In Brief This Week: Thermo Fisher, Grifols, MDxHealth, Exosome Diagnostics, and More Nov 30, 2016 Evotec Inks Deal to Offer Merck KGaA Gene Editing, Silencing Technologies Jul 6, 2016 Evotec Licenses CRISPR Tech From Broad Institute, Harvard Sep 11, 2014 CHDI Extends Evotec Huntington's Collaboration Through 2017 Apr 25, 2014 Evotec-Roche Deal Indicates Adoption of Mass Spec, Hi-Res Instrumentation for Clinical Protein Quant Premium Sep 12, 2013 Evotec, HSCI Ink ALS Deal Sep 6, 2013 String of Recent Deals Suggests Ag-Bio Market an Opportunity for Chemical Proteomics Firms Premium Aug 21, 2013 Evotec, Jain Foundation Expand Muscular Dystrophy Collaboration Jul 9, 2013 Evotec, Dow AgroSciences Enter Proteomics Service Deal Jan 4, 2013 Evotec Inks Deal with Apeiron to Use Chemical Proteomics in Cancer Drug Development Premium Jan 3, 2013 Evotec Buys Cell-based Reagents Firm for up to $2.9M Sep 21, 2012 In Brief This Week: Roche; Life Technologies; Trovagene, Strand; Fluidigm; Wellington Partners; Proteros, UCB; Evotec May 18, 2012 GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build Premium Apr 20, 2012 UNC Team Takes Proteomic Approach to Study Drug Resistance in Triple-Negative Breast Cancer Premium Jul 1, 2011 Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche Premium Jun 24, 2011 Roche, Evotec Partner on Protein Biomarkers for Cancer Drugs Load More Breaking News People in the News at Probius, Flagship Biosciences, Discovery Life Sciences, More New Products Posted to GenomeWeb: BillionToOne, Becton Dickinson, Enzo Biochem, More Stroke Risk Contributors, Treatment Targets Uncovered in Cross-Ancestry GWAS In Brief This Week: Yourgene Health, Bionano Laboratories, Caris Life Sciences, More Enzymatic RNA Synthesis Firm EnPlusOne Biosciences Launches With $12M in Seed Funding The Scan Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says. Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds. Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry. UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.